TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2024
Back to search
Official data from USPTO
BREAK THE SILENCE ON OVARIAN CANCER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BREAK THE SILENCE ON OVARIAN CANCER
ST13
US500000085298245Class
35, 44, 45
Filing
85298245
Registration
4165659
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
02/16/2024
Trademark type
Word
Nice classes
35, 44, 45
Filing date
04/18/2011
Registration date
06/26/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/25/2022
Last transaction
02/16/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2011-06-00
First use in commerce
2011-06-00
Drawing code
4
Owner type
99
Owner location
Dallas, TX, US
Examiner
FISHER, HANNAH
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
National Ovarian Cancer Coalition, Inc.
National Ovarian Cancer Coalition, Inc.
Representatives
Deborah L. Lively Pierson Ferdinand LLP
Technical classification
Nice Classes
Class 35Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Association servicespromoting the interests of those with ovarian cancer
Class 44
Providing medical information regarding ovarian cancer treatment and the detection and management of related symptoms in order to improve the survival rate and quality of life for women with ovarian cancer
Class 45
Providing information about how to deal with and process personal emotions related to ovarian cancer treatment in order to improve the survival rate and quality of life for women with ovarian cancer
Publications
History of USPTO decisions and trademark events.
32 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/25/2022
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/25/2022
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
03/25/2022
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
03/25/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/25/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/17/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/26/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/25/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/25/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/25/2018
E815
TEAS SECTION 8 & 15 RECEIVED
06/13/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/26/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
05/24/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/23/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/15/2012
ALIE
ASSIGNED TO LIE
05/14/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/23/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/19/2012
IUAF
USE AMENDMENT FILED
03/28/2012
EISU
TEAS STATEMENT OF USE RECEIVED
03/28/2012
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/11/2011
PUBO
PUBLISHED FOR OPPOSITION
08/16/2011
NPUB
NOTICE OF PUBLICATION
07/27/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2011
DOCK
ASSIGNED TO EXAMINER
06/28/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/21/2011
NWAP
NEW APPLICATION ENTERED
04/21/2011
Continuous trademark protection
Get notified about every new filing that threatens BREAK THE SILENCE ON OVARIAN CANCER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.